Straumann Holding AG (OTCMKTS:SAUHY) was the target of a significant decline in short interest in the month of September. As of September 30th, there was short interest totalling 3,300 shares, a decline of 52.2% from the September 15th total of 6,900 shares. Based on an average daily volume of 19,600 shares, the short-interest ratio is currently 0.2 days.
SAUHY has been the subject of a number of recent analyst reports. JPMorgan Chase & Co. reaffirmed an “overweight” rating on shares of Straumann in a research report on Monday, August 16th. Exane BNP Paribas raised Straumann from a “neutral” rating to an “outperform” rating in a research report on Thursday, July 8th. UBS Group boosted their price target on Straumann from CHF 1,230 to CHF 1,745 and gave the company a “neutral” rating in a research report on Friday, August 20th. BNP Paribas raised Straumann from a “neutral” rating to an “outperform” rating in a research report on Thursday, July 8th. Finally, Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Straumann in a research report on Friday, October 8th. One analyst has rated the stock with a sell rating, three have issued a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat, Straumann presently has a consensus rating of “Hold” and a consensus target price of $1,745.00.
Shares of SAUHY traded up $5.06 during midday trading on Thursday, reaching $95.99. 138,955 shares of the company were exchanged, compared to its average volume of 13,589. The stock has a 50-day moving average price of $95.86 and a 200-day moving average price of $83.93. Straumann has a 1-year low of $49.84 and a 1-year high of $106.46.
Straumann Holding AG engages in the provision of implant, restorative, and regenerative dentistry solutions to dental professionals and laboratories. It operates through the following segments: Sales Europe, Sales Distributor & Emerging Markets EMEA, Sales NAM, Sales APAC, Sales LATAM, and Operations.
Featured Article: What is a capital gain?
Receive News & Ratings for Straumann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Straumann and related companies with MarketBeat.com's FREE daily email newsletter.